The Lancet: First nationally representative estimate of COVID-19 seroprevalence in the U.S. suggests few in the population developed antibodies in the first wave

Nation-wide cross-sectional analysis of U.S. patients receiving dialysis finds fewer than 10% of people had COVID-19 antibodies by July 2020, and fewer than 10% of those with antibodies had been diagnosed by antigen or PCR testing.

Read more